9976
F. R. Cibin et al. / Tetrahedron 59 (2003) 9971–9978
1H NMR (DMSO-d6),§ d¼3.18 [bs, OH], 3.62 [s, 4H,
–O–CH2], 3.72–3.82 [m, 4H, –O–CH2], 4.10–4.20 [m,
131.31 [C-quat.], 143.65 [C-1], 160.70 [C-quat.], 162.45
[C-quat.], 188.43 [CvO].
0
0
4H, –O–CH2], 6.88 [AA XX , JH–H¼8.8 Hz, 4H, H-30],
3
0
0
00
3
6.99 [AA XX , 3JH–H¼8.8 Hz, 4H, H-3 ], 7.61 [d, JH–H
¼
UV–vis (CHCl3), lmax 336 nm, 1 5.0£104 cm21 dm3 mol21
.
15.6 Hz, 2H, H-1], 7.71 [d, 3JH–H¼15.6 Hz, 2H, H-2], 7.76
[AA0XX0, JH – H¼8.8 Hz, 4H, H-20], 8.02 [AA0XX0,
IR (CHCl3), nmax(CvO) 1656 cm21
.
3
3JH–H¼8.8 Hz, 4H, H-200].
MS (IS) m/z¼709 (MþH)þ.
13C NMR (DMSO-d6),§ d¼67.33, 68.88, 69.95 [–O–CH2],
114.85 [C-300], 115.32 [C-30], 119.61 [C-2], 127.57
[C-quat.], 129.30 [C-200], 130.54 [C-20], 131.03 [C-quat.],
142.65 [C-1], 160.34 [C-quat.], 162.04 [C-quat.], 187.04
[CvO].
Anal. calcd for C42H44O10 C 71.17, H 6.26. Found C 71.40,
H 6.16.
1
Compound 1c. H NMR (CDCl3),§ d¼3.65–3.80 [m, 8H,
–O–CH2], 3.85–4.00 [m, 8H, –O–CH2], 4.06–4.13
[m, 4H, –O–CH2], 4.13–4.20 [m, 4H, –O–CH2], 6.80
IR (CHCl3), nmax(CvO) 1673 cm21
MS (IS) m/z¼595 (MþH)þ.
.
[AA0XX0, JH – H¼8.7 Hz, 4H, H-300], 6.88 [AA0XX0,
3
3JH–H¼8.7 Hz, 4H, H-30], 7,33 [d, JH–H¼15.5 Hz, 2H,
3
0
0
H-2], 7.46 [AA XX , JH–H¼8.7 Hz, 4H, H-200], 7.73 [d,
4H, H-20].
3
0
0
3
Anal. calcd for C36H34O8 C 72.71, H 5.76. Found C 72.92,
H 5.62.
3JH–H¼15.5 Hz, 2H, H-1], 7.92 [AA XX , JH–H¼8.7 Hz,
4.3.3. General procedure for the preparation of
9,12,15,18,30,33,36,39-octaoxapentacyclo-[38.2.2.25,8
2
13C NMR (CDCl3),‡,§ d¼67.64, 67.70, 69.44, 69.96, 70.81
[–O–CH2], 114.28 [C-30], 115.36 [C-300], 119.11 [C-2],
127.80 [C-quat.], 129.88 [C-200], 130.53 [C-20], 131.25
[C-quat.], 143.66 [C-1], 160.66 [C-quat.], 162.43 [C-quat.],
188.28 [CvO].
.
19,22.226,29]-pentaconta-1(42),3,5,7,19,21,23,26,28,40,43,
45,47,49-tetradecaene-2,25-dione (1b) and 9,12,15,27,
30,33,36,39-octaoxapentacyclo-[38.2.2.25,8.216,19.223,26]-
pentaconta-1(42),3,5,7,16,18,20,23,25,40,43,45,47,49-tetra-
decaene-2,22-dione (1c). A solution containing 3b (or 3c)
(1 mmol) in dry DMF (200 mL) was added dropwise (ca.
5 h), to a stirred suspension of 5b (or 5a) (1 mmol) and dry
K2CO3 (690 mg, 1 mmol) in dry DMF (800 mL) and kept
under argon at 808C. The stirring was continued at this
temperature for ,3 days until complete consumption of 5,
as established by reverse phase TLC (CH3CN/H2O 7:3).
The resulting mixture was cooled and filtered to remove
K2CO3. The recovered K2CO3 was washed with DMF, the
organic phases were collected and solvent removed in vacuo
to yield a solid residue that was dissolved in CHCl3, washed
with water and dried on Na2SO4. The solvent was removed
in vacuo to yield a solid that was purified by flash
chromatography (CHCl3/acetone 9:1). Recrystallization
from CHCl3/MeOH yielded the cyclic bis-chalcone 1b
(55%, mp 203–2048C) or 1c (51%, mp 161–1628C) as
yellow solid.
UV–vis (CHCl3), lmax 336 nm, 1 3.9£104 cm21 dm3 mol21
.
IR (CHCl3), nmax(CvO) 1655 cm21
.
MS (IS) m/z¼709 (MþH)þ.
Anal. calcd for C42H44O10 C 71.17, H 6.26. Found C 71.42,
H 6.18.
4.3.4. General procedure for the preparation of
9,12,15,18,30,33,36,39-octaoxaheptacyclo-[38.2.2.25,8
.
2
19,22.226,29.02,25.03,24]-pentaconta-1(42),5,7,19,21,26,28,
40,43,45,47,49-dodecaene-4,23-dione (2b) and 9,12,15,27,
30,33,36,39-octaoxaheptacyclo-[38.2.2.25,8.216,19.223,26
2,22.03,21]-pentaconta-1(42),5,7,16,18,20,23,25,40,43,45,
.
0
47,49-dodecaene-4,20-dione (2c). Photoisomerization in
sunlight. A solution of 1b or 1c (0.163 mmol) in 50 mL of
chloroform, kept in a Pyrex flask, was exposed to
sunlight on a sunny day of April. The progress of the
reaction was followed by silica gel TLC (CHCl3) and
reverse phase TLC (CH3CN/H2O 8:2). The reaction was
stopped after ,2 h. The solution was evaporated and
the residue purified by flash chromatography (2b:
CHCl3/acetone 8:2, 68%; 2c: CHCl3/acetone 9:1, 71%).
Recrystallization from chloroform-methanol (2b) or
acetone (2c) gave microscopic white needles of an
analytically pure sample. (2b: mp 183–1848C; 2c: mp
203–2048C).
Compound 1b. 1H NMR (CDCl3),§ d¼3.72 and 3.76
[partially superimposed singlets, 8H, –O–CH2], 3.80–
3.90 [m, 8H,0 –O–CH2], 4.05–4.15 [m, 8H, –O–CH2],
0
6.86 [AA XX , JH–H¼8.6 Hz, 4H, H-300], 6.89 [AA0XX0,
3
3JH–H¼8.9 Hz, 4H, H-30], 7.32 [d, 3JH–H¼15.5 Hz, 2H, H-2],
0
0
0
3
3
7.48 [AA XX , JH–H¼8.6 Hz, 4H, H-2 ], 7.70 [d, JH–H
¼
15.5 Hz, 2H, H-1], 7.92 [AA0XX0, 3JH–H¼8.9 Hz, 4H, H-20].
13C NMR (CDCl3),‡,§ d¼67.46, 67.49, 69.54, 69.63, 70.94,
70.97 [–O–CH2], 114.35 [C-30], 115.02 [C-300], 119.30
[C-2], 127.80 [C-quat.], 130.03 [C-200], 130.58 [C-20],
Photoisomerization at 350 nm. A 6.44£1023 mol dm23
solution of 1b or 1c (25 mL) in chloroform, contained in a
Pyrex flask, was irradiated in a Rayonet reactor by 14 lamps
whose emission was centred at 350 nm. After ca. 30 min the
reaction appeared to be completed. The solvent was
removed and the residue purified by flash chromatography
(yield: 2b, 81%; 2c, 86%).
§
For the sake of simplicity, the atom numbers indicated in NMR spectra
are referred to those indicated in Scheme 2 (compounds 1b, 1c and 5b),
and Figure 5 (compound 2c; N.B., in the case of 2b: 200a¼200d¼200,
300b¼300c¼300).
‡
Erratum: in Ref. 1 is reported an erroneous assignment for C-30 and C-300
of 1a. The correct assignment is: 114.64 [C-30], 115.34 [C-300].